DR. THOMAS JOHN BARANSKI, MD
Osteopathic Medicine at Childrens Pl, Saint Louis, MO

License number

Missouri 2000154619

Personal information

See more information about THOMAS JOHN BARANSKI at radaris.com

Name

Address

Phone

Thomas Baranski

819 Craig Forest Ln, Saint Louis, MO 63122

Thomas Baranski

819 Craig Forest Ln, Saint Louis, MO 63122

Professional information

See more information about THOMAS JOHN BARANSKI at trustoria.com

Dr. Thomas J Baranski, Saint Louis MO - MD (Doctor of Medicine)

Specialties:

Endocrinology, Diabetes & Metabolism

Address:

Saint Louis Office
660 S Euclid Ave, Saint Louis 63110
(314) 362-5000 (Phone), (314) 454-5396 (Fax)
Washington University Endo
4921 Parkview Pl SUITE C, Saint Louis 63110
(314) 362-3500 (Phone)
Medicine Multispecialty Center
4921 Parkview Pl SUITE 5C, Saint Louis 63110
(314) 747-9150 (Phone)

Certifications:

Diabetes, Metabolism & Endocrinology, 2011, Internal Medicine, 1995

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
Washington Center / School of Medicine
Graduated: 1992
University Of California-San Francisco

Associate Professor, Washington University School Of Medicine

Location:

Greater St. Louis Area

Industry:

Biotechnology

Thomas John Baranski, Saint Louis MO

Specialties:

Endocrinologist

Address:

4570 Childrens Pl, Saint Louis, MO 63110

Education:

Washington University, School of Medicine - Doctor of Medicine*
UCSF Medical Center - Residency - Internal Medicine*

Board certifications:

American Board of Internal Medicine Sub-certificate in Endocrinology, Diabetes, and Metabolism (Internal Medicine)*

Thomas John Baranski, Saint Louis MO

Specialties:

Internal Medicine, Endocrinology, Diabetes & Metabolism

Work:

Washington University at St. Louis
4570 Childrens Pl, Saint Louis, MO 63110

Education:

Washington University at St. Louis (1992)

High Throughput Cancer Pharmaceutical Screening Using Drosophila

US Patent:

2006001, Jan 12, 2006

Filed:

Jun 16, 2005

Appl. No.:

11/154035

Inventors:

Thomas Baranski - Kirkwood MO, US
Ross Cagan - Clayton MO, US

International Classification:

A01K 67/033

US Classification:

800010000, 800013000

Abstract:

High throughput drug screening assay methods and related apparatus are described. with screenably distinct characteristics are raised in multi-well microtiter plates on standard growth medium. Screenably distinct characteristics which mimic human cancer or cancer-related condition are established by modifying expression of an oncogene or tumor suppressor in the . Compounds that putatively modify the screenably distinct characteristic are then tested by feeding the compounds to the embryos, and determining whether the compound modifies the screenably distinct characteristic induced by modifying gene expression. The assay methods and related articles of composition can also be used to simultaneously assay toxicity of candidate compounds.

High Throughput Pharmaceutical Screening Using Drosophila

US Patent:

2005026, Nov 24, 2005

Filed:

Jan 14, 2005

Appl. No.:

11/036897

Inventors:

Thomas Baranski - Kirkwood MO, US
Ross Cagan - Clayton MO, US

International Classification:

A61K049/00

US Classification:

424009200

Abstract:

High throughput drug screening assay methods and related apparatus are described. Wild-type are raised in multi-well microtiter plates on a growth medium having a high level of a sugar such as glucose. The high sugar diet during development induces screenably distinct characteristics in the wild-type . Compounds that putatively modify the screenably distinct characteristic are tested by feeding to the embryos, and determining whether the compound modifies the screenably distinct characteristic induced by the high sugar growth medium. The assay methods and related articles of composition can also be used to assay toxicity of candidate compounds.